Inventor
FLANAGAN JOHN
US51 patents
⚠️ This page may combine multiple inventors who share the name “FLANAGAN JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IBM
14 patentsUS11038698B2Jun 15, 2021
Securing a path at a selected node
IBM7 citations83
US10764291B2Sep 1, 2020
Controlling access between nodes by a key server
IBM7 citations83
US11563588B2Jan 24, 2023
Securing a path at a selected node
IBM4 citations74
US10833856B2Nov 10, 2020
Automatic re-authentication of links using a key server
IBM6 citations73
US11308243B2Apr 19, 2022
Maintenance of access for security enablement in a storage device
IBM2 citations72
US11088829B2Aug 10, 2021
Securing a path at a node
IBM3 citations72
US11038671B2Jun 15, 2021
Shared key processing by a storage device to secure links
IBM4 citations72
US11025413B2Jun 1, 2021
Securing a storage network using key server authentication
IBM4 citations72
US10833860B2Nov 10, 2020
Shared key processing by a host to secure links
IBM5 citations72
US12299185B2May 13, 2025
Maintenance of access for security enablement in a storage device
IBM0 citations62
US11522681B2Dec 6, 2022
Securing a path at a node
IBM0 citations62
US8032581B2Oct 4, 2011
Persistent information unit pacing
IBM4 citations62
US10223013B2Mar 5, 2019
Processing input/output operations in a channel using a control block
IBM0 citations48
US9715466B1Jul 25, 2017
Processing input/output operations in a channel using a control block
IBM1 citations48
AMICUS THERAPEUTICS INC
9 patentsUSRE48608EJun 29, 2021
Method to predict response to pharmacological chaperone treatment of diseases
AMICUS THERAPEUTICS INC36 citations97
US10813921B2Oct 27, 2020
Method to predict response to pharmacological chaperone treatment of diseases
AMICUS THERAPEUTICS INC39 citations97
US9545397B2Jan 17, 2017
Method to predict response to pharmacological chaperone treatment of diseases
AMICUS THERAPEUTICS INC50 citations97
US9303249B2Apr 5, 2016
High concentration α-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC15 citations92
US9404100B2Aug 2, 2016
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC16 citations90
US10512677B2Dec 24, 2019
High concentration alpha-glucosidase compositions for the treatment of pompe disease
AMICUS THERAPEUTICS INC4 citations83
US10046033B2Aug 14, 2018
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC4 citations83
US12419937B2Sep 23, 2025
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC0 citations62
US11278599B2Mar 22, 2022
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC0 citations62
FEI CO
5 patentsUS11151356B2Oct 19, 2021
Using convolution neural networks for on-the-fly single particle reconstruction
FEI CO2 citations71
US12362137B2Jul 15, 2025
Automated sample alignment for microscopy
FEI CO0 citations62
US12567165B2Mar 3, 2026
Critical dimension measurement in 3D with geometric models
FEI CO0 citations55
US12293525B2May 6, 2025
Artificial intelligence enabled metrology
FEI CO0 citations52
US11569056B2Jan 31, 2023
Parameter estimation for metrology of features in an image
FEI CO0 citations51
PHARMACIA CORP
3 patentsMONSANTO CO
3 patentsSTRECK INC
3 patents(unassigned)
1 patentBENJAMIN ELFRIDA
1 patentAMICUS THERAPEUTICS
1 patentKEATING WILLIAM
1 patentMEDISPECTRA INC
1 patentICI PLC
1 patentBIO RAD LABORATORIES
1 patentSTRECK LLC
1 patentBIO RAD LABORATORIES INC
1 patentFLANAGAN JOHN
1 patentARVINAS OPERATIONS INC
1 patentBIO RAD EUROPE GMBH
1 patentMCCAVITT KATE
1 patentShowing the top 50 of 51 patents by PatentIndex Score.